Fractyl Health (GUTS) Accounts Payables (2023 - 2026)
Fractyl Health's (GUTS) quarterly Accounts Payables came in at $1.6 million in Q1 2026, up 11.49% YoY from $1.5 million in Q1 2025, and up 4.76% on a QoQ basis from $1.6 million in Q4 2025.
Fractyl Health (GUTS) Accounts Payables (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Accounts Payables data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Accounts Payables rose 11.49% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 11.49% YoY) and the FY2025 annual result came in at $1.6 million, down 51.42% from the prior year.
- Accounts Payables grew to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $3.9 million in Q2 2025 to a low of $553000.0 in Q4 2023.
- A 4-year average of $1.9 million and a median of $1.6 million in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables surged 485.9% — and 2025, when it plunged 51.42%.
- Tracing GUTS's Accounts Payables over 4 years: stood at $553000.0 in 2023, then surged by 485.9% to $3.2 million in 2024, then sank by 51.42% to $1.6 million in 2025, then rose by 4.76% to $1.6 million in 2026.
- The last three Accounts Payables figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 553,000.00 |